Size Does Matter: Can we Reduce the Radiotherapy Field Size for Selected Cases of Anal Canal Cancer Undergoing Chemoradiation?
- 30 June 2009
- journal article
- Published by Elsevier BV in Clinical Oncology
- Vol. 21 (5), 376-379
- https://doi.org/10.1016/j.clon.2009.01.015
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivorsClinical Oncology, 2004
- Cancer of the anal canalThe Lancet Oncology, 2004
- TNM Classification of Malignant TumoursPublished by Wiley ,2003
- Carcinoma of the Anal CanalNew England Journal of Medicine, 2000
- Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.Journal of Clinical Oncology, 1997
- Combined radiotherapy and chemotherapy for anal cancerThe Lancet, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin CInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Epidermoid carcinoma of the anal canalDiseases of the Colon & Rectum, 1987
- Combined therapy for cancer of the anal canalDiseases of the Colon & Rectum, 1974